Regen BioPharma Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
115.90
-
38.60
24.80
270.00
8
Total Accounts Receivable
-
10.70
13.40
112.60
174.00
12.20
Other Current Assets
-
-
10.00
69.90
34.40
22.50
Total Current Assets
115.90
10.70
62.10
207.40
478.40
42.80
Total Investments and Advances
-
-
158.40
112.00
465.90
166.20
Total Assets
115.90
10.70
220.50
319.40
944.20
209
ST Debt & Current Portion LT Debt
-
126.30
222.80
152.50
380.20
Accounts Payable
-
-
25.90
240.80
495.70
Other Current Liabilities
-
14.00
69.00
406.00
4,987.20
Total Current Liabilities
-
140.30
317.60
799.20
5,863.20
Long-Term Debt
-
-
-
107.10
332.40
Total Liabilities
-
140.30
317.60
906.30
6,195.60
Common Equity (Total)
115.90
129.60
103.30
600.40
5,268.20
Total Shareholders' Equity
115.90
129.60
97.20
586.90
5,251.30
Total Equity
115.90
129.60
97.20
586.90
5,251.30
Liabilities & Shareholders' Equity
115.90
10.70
220.50
319.40
944.20
Preferred Stock (Carrying Value)
-
-
6.10
13.50
16.90
About Regen BioPharma
View Profile
